Phase 3 Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older.
- A doctor has officially diagnosed you with asthma at least 12 months ago.
- You have been taking a medium or high dose of inhaled asthma controller medication (called ICS) for at least 6 months.
- You have been on a medium or high dose of this inhaled controller medication for at least 3 months continuously (confirm with trial site for exact dose definitions).
- You are also taking at least one other daily asthma controller medication, and have been for at least 3 months.
- Your lung function test (a breathing test called FEV1) shows your lungs are working at less than 80% of what is expected for someone your age and size.
- There is objective medical evidence confirming your asthma diagnosis (confirm with trial site).
- You have had at least 2 asthma attacks (flare-ups) in the past 12 months, and at least one of those happened while you were already on medium-to-high dose inhaled medication.
- Your asthma symptom questionnaire score (ACQ-6) shows your asthma is not well controlled at the start of the study.
- You have completed at least 70% of required daily electronic health questionnaires in the 7 days before joining the study.
Who may not be able to join:
- You have a significant lung or breathing condition other than asthma.
- You have a history of cancer.
- You have a history of a serious infection (confirm with trial site for details).
- You are currently a smoker, or you have smoked heavily in the past (10 pack-years or more).
- You have had issues with alcohol or drug misuse in the past 12 months.
- You have hepatitis B, hepatitis C, or HIV.
- You are currently pregnant or breastfeeding.
- You have previously had a severe allergic reaction (anaphylaxis) to any biologic medicine.
- You have already taken part in this study or a previous study involving the medicine called SHR-1905.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-020-62726806
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Annual asthma exacerbation rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.